Get started
Work

Figure S1, S2, S3 from Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients

Year: 2023
Type: other
Abstract: Supplemental Figure 1: Case of advanced NSCLC with high level EGFR T790M mutation on plasma next-generation sequencing (NGS). Supplemental Figure 2: Distribution of variant AFs between 25% and 75% across 105 cases of plasma NGS. Supplemental Figure 3: Plasma NGS cases positive for EGFR T790M submitted for blinded validation.
DOI: 10.1158/1078-0432.22466105.v1
Authors: Yuebi Hu, Ryan S. Alden, Justin I. Odegaard, Stephen R. Fairclough, Ruthia Chen, Jennifer Heng, Nora Feeney, Rebecca J. Nagy, Jayshree Shah, Bryan Ulrich, Martin Gutierrez, Richard B. Lanman, Judy E. Garber, Cloud P. Paweletz, Geoffrey R. Oxnard
Language: English
Subfield: Cancer Research
Open Access status: gold
OpenAlex ID: W4361928069
Cites:
Cited by:
Related to: 10